Doctors quested if they would use generics of Baraclude soon expired in patent
The so-called ‘Big 5’ treatment market, expired in patent this year, has attracted the industry. Among the Big 5, the patent of Lilly’s Alimta was expired for the first time on May this year, and Pfizer’s ‘Celebrex’ and Dong-A ST’s ‘Stillen’ were also expired in patent on June and July, respectiv...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
